IL-37 Plays a Beneficial Role in Patients with Acute Coronary Syndrome
Background. Interleukin-37 (IL-37) acts as an inhibitor of innate and adaptive immunity. However, the exact role of IL-37 in the patients with acute coronary syndrome (ACS) remains to be elucidated. Methods. Patients were classified into 4 groups: normal coronary artery (NCA), stable angina (SA), un...
Saved in:
| Main Authors: | Xiaobo Mao, Ruirui Zhu, Fangyuan Zhang, Yucheng Zhong, Kunwu Yu, Yuzhen Wei, Haitao Sun, Wenbin Xu, Quan Luo, Yue Wang, Yan Ding, Qiutang Zeng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2019/9515346 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
by: Ruirui Zhu, et al.
Published: (2016-12-01) -
Elevated Plasma IL-37, IL-18, and IL-18BP Concentrations in Patients with Acute Coronary Syndrome
by: Qingwei Ji, et al.
Published: (2014-01-01) -
Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment
by: Yucheng Zhong, et al.
Published: (2015-01-01) -
Interleukin-27 Ameliorates Atherosclerosis in ApoE-/- Mice through Regulatory T Cell Augmentation and Dendritic Cell Tolerance
by: Wenbin Xu, et al.
Published: (2022-01-01) -
Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals
by: Ruirui Zhu, et al.
Published: (2015-01-01)